PUMA BIOTECHNOLOGY, INC. Preferred Stock, Shares Authorized
PUMA BIOTECHNOLOGY, INC. (PBYI) had Preferred Stock, Shares Authorized of 10.00 million shares as of 2017-12-31, per its 10-K filed 2018-03-09.
Discontinued › Balance Sheet › Equity › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockSharesAuthorized · last filed 2018-03-09
- 2017-12-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2016-12-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2015-12-31: Preferred Stock, Shares Authorized 10.00M shares.
- 2014-12-31: Preferred Stock, Shares Authorized 10.00M shares.
| Period end | Preferred Stock, Shares Authorized |
|---|---|
| 2017-12-31 | 10.00M shares 10-K · filed 2018-03-09 |
| 2016-12-31 | 10.00M shares 10-K · filed 2017-03-01 |
| 2015-12-31 | 10.00M shares 10-K · filed 2016-02-29 |
| 2014-12-31 | 10.00M shares 10-K · filed 2015-03-02 |
| 2013-12-31 | 10.00M shares 10-K · filed 2014-03-03 |
| 2012-12-31 | 10.00M shares 10-K · filed 2013-04-01 |
| 2011-06-30 | 10.00M shares 10-Q · filed 2011-08-15 |
| 2010-12-31 | 10.00M shares 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |